Searched for
COST PLUS DRUGS PARTNERSHIP
INERA and CropNXT announce strategic partnership to reach 65 lakh farmers, unlock Rs 500 crore business opportunityBiological agri-input firm INERA Crop Science has partnered with CropNXT Solutions to boost its presence in eastern and northern India. The...
Telangana plans drug discovery push to move Hyderabad up pharma value chainTelangana is charting a new course to elevate Hyderabad into a global drug discovery hub. The state is fostering an integrated ecosystem by...
Indian electronics manufacturers forge more and more partnerships with companies from South Korea, Taiwan, JapanIndian electronics manufacturers are forging alliances with firms from South Korea, Taiwan and Japan, alongside exploring standalone initia...
'Cheaper than a gym, but still not selling': Nithin Kamath on why Indians aren't embracing popular weight-loss drugsDespite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges wi...
India launches UPI in GreeceIndia's digital payment system, UPI, has expanded its global reach with a launch in Greece. This move allows eligible customers instant, se...
Netradyne announces partnership with GeosecureThe technology focuses on real-time intervention for risky behaviors and rewards safe driving, addressing critical issues like driver fatig...
Bitcoin is boring. Bring on AI, space and JGB tokensForget Bitcoin's struggles; digital tokens representing real-world assets like bonds and stocks are gaining traction. These 'tokenized asse...
Strides Pharma sells majority stake in arm Pivot Path for Rs 100 croreStrides Pharma Science has divested a majority stake in its subsidiary, Pivot Path, for Rs 100 crore to a consortium led by Ascent Capital ...
Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for those who are not diabetic or clinically obese...'Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...
Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
Manipur CM says drug trafficking routes have changed after 2023 crisis, largely diverting through MizoramManipur Chief Minister Yumnam Khemchand Singh revealed that drug trafficking routes have shifted significantly post-2023 crisis, largely di...
India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug salesInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...
Govt to amend NDPS Act to plug loopholes exploited by narco syndicates: Amit ShahUnion Home Minister Amit Shah announced plans to amend the NDPS Act to combat drug syndicates, emphasizing a strict approach against peddle...
Health ministry issues proposal for one-year residual shelf life for imported drugsThe Union Health Ministry is proposing to relax import rules for medicines, requiring a minimum 12-month shelf life upon arrival instead of...
CDSCO asks states, port offices to step up screening to curb imports of illegal drugsIndia's drug regulator is intensifying border screenings to block unapproved medicines from entering the country. Authorities are cracking ...
All you need to know about Meta’s Instagram, Whatsapp and Facebook subscription plans in IndiaMeta has launched paid subscription plans for WhatsApp, Instagram, and Facebook in India, offering customisation and convenience features f...
India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI AayogIndia's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...